Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and ...
At close: February 7 at 4:00:02 PM EST ...
After hours: 7:56:36 p.m. EST ...
At close: February 7 at 3:00:00 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback